ARTICLE | Company News
Plexus, GlaxoSmithKline deal
July 29, 2002 7:00 AM UTC
GSK's GlaxoSmithKline Biologicals subsidiary (Rixensart, Belgium) and Plexus partnered to develop structure-based rational antibody vaccines. Plexus will use its structure-based vaccine design methods...